Literature DB >> 10779683

NADH-dependent decavanadate reductase, an alternative activity of NADP-specific isocitrate dehydrogenase protein.

A V Rao1, T Ramasarma.   

Abstract

The well known NADP-specific isocitrate dehydrogenase (IDH) obtained from pig heart was found to oxidize NADH with accompanying consumption of oxygen (NADH:O(2)=1:1) in presence of polyvanadate. This activity of the soluble IDH-protein has the following features common with the previously described membrane-enzymes: heat-sensitive, active only with NADH but not NADPH, increased rates in acidic pH, dependence on concentrations of the enzyme, NADH, decavanadate and metavanadate (the two constituents of polyvanadate), and sensitivity to SOD and EDTA. Utilizing NADH as the electron source the IDH protein was able to reduce decavanadate but not metavanadate. This reduced form of vanadyl (V(IV)) was similar in its eight-band electron spin resonance spectrum to vanadyl sulfate but had a 20-fold higher absorbance at its 700 nm peak. This decavanadate reductase activity of the protein was sensitive to heat and was not inhibited by SOD and EDTA. The IDH protein has the additional enzymic activity of NADH-dependent decavanadate reductase and is an example of "one protein--many functions".

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779683     DOI: 10.1016/s0304-4165(00)00026-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Decavanadate interacts with microsomal NADH oxidation system and enhances cytochrome c reduction.

Authors:  T Ramasarma; Aparna V S Rao
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 2.  Decavanadate Toxicology and Pharmacological Activities: V10 or V1, Both or None?

Authors:  M Aureliano
Journal:  Oxid Med Cell Longev       Date:  2016-01-21       Impact factor: 6.543

Review 3.  Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Brenda L Sanchez-Gaytan; Jose Manuel Perez-Aguilar; Enrique González-Vergara
Journal:  Biol Trace Elem Res       Date:  2018-10-22       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.